Pflügers Archiv

, Volume 423, Issue 3–4, pp 251–254 | Cite as

Effects of dichloroacetate on exercise performance in healthy volunteers

  • Bernhard Ludvik
  • Gert Mayer
  • Sibylle Stifter
  • Dinah Putz
  • Ursula Barnas
  • Helmut Graf
Heart, Circulation, Respiration and Blood; Environmental and Exercise Physiology

Abstract

Dichloroacetate (DCA), a stimulator of the pyruvate dehydrogenase complex, decreases lactate levels and peripheral resistance and increases cardiac output. This study was performed to examine the effects of DCA on exercise performance in humans. Eight healthy male volunteers (age 20–28 years) were tested by bicycle spiro-ergometry using a microprocessor-controlled gas analysis system after infusion of DCA (50 mg/kg body weight) or saline. Prior infusion of DCA significantly reduced the increase of lactate levels during exercise when compared with infusion of saline (1.40±0.21 vs 2.10±0.09 mmol·l−1 at 50% of the expected maximal working capacity, P<0.05; 8.53±0.45 vs 9.92±0.59 mmol·l−1 at maximal working capacity, P<0.05). Oxygen uptake increased significantly after DCA when compared with saline from 7.5±0.4 vs 7.4±0.5 to 27.2±1.5 vs 23.7±1.7 (P<0.05) at anaerobic threshold and to 35.6±1.7 vs 30.5±1.0 ml · kg−1 min−1 (P<0.05) at maximal exercise capacity. Following DCA infusion the workload at which the anaerobic threshold was reached was significantly higher (160±7 vs 120±5 W, P<0.05) and the maximal working capacity was significantly increased (230±9 vs 209±8 W, P<0.05). In summary, DCA reduced the increase of lactate levels during exercise and increased oxygen uptake at the anaerobic threshold and at maximal working capacity, which was significantly increased. These results warrant further studies on a potential therapeutic application of DCA in patients with reduced exercise capacity.

Key words

Exercise Anaerobic threshold Oxygen uptake Maximal working capacity Dichloroacetate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brooks GA (1985) Anaerobic threshold: review of the concept and directions for future research. Med Sci Sports Exerc 17:22–31Google Scholar
  2. 2.
    Crabb DW, Yount EA, Harris RA (1981) The metabolic effects of dichloroacetate. Metabolism 30:1024–1039Google Scholar
  3. 3.
    Graf H, Leach W, Arieff AI (1985) Effect of dichloroacetate in the treatment of lactic acidosis in dogs. J Clin Invest 76:919–923Google Scholar
  4. 4.
    Hayek A, Woodside WF (1980) Short-term influences of dichloroacetate on genetically hyperlipaemic rats. Metabolism 29:120–124Google Scholar
  5. 5.
    Ludvik B, Peer G, Berzlanovich A, Stifer S, Graf H (1991) Effects of dichloroacetate and bicarbonate on hemodynamic parameters in healthy volunteers. Clin Sci 80:47–51Google Scholar
  6. 6.
    Merrill GF, Rosolowsky M (1980) Effect of dichloroacetate sodium on lactacidemia of experimental endotoxin shock. Circ Shock 7:13–21Google Scholar
  7. 7.
    Moore GW, Swift LL, Rabinowitz D, Crofford OB, Oates JA, Stacpoole PW (1979) Reduction of serum cholesterol in two patients with homozygous familial hypercholesterolaemia by dichloroacetate. Atherosclerosis 33:285–293Google Scholar
  8. 8.
    Norton AC (1979) Development of a microprocessor controlled system for gas exchange and related variables in man during rest and exercise. Reprint No. 025, Beckman, New YorkGoogle Scholar
  9. 9.
    Park R, Radosevich PR, Leach WJ, Seto P, Arieff AI (1983) Metabolic effects of dichloroacetate in diabetic dogs. Am J Physiol 245:E 94-E 101Google Scholar
  10. 10.
    Randle PJ (1976) Regulation of glycolysis and pyruvate oxidation in cardiac muscle. Circ Res 38 [Suppl 1]:I 8-I 15Google Scholar
  11. 11.
    Stacpoole PW (1989) The pharmacology of dichloroacetate. Metabolism 38:1124–1144Google Scholar
  12. 12.
    Stacpoole PW, Moore GW, Kornhauser DM (1978) Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinaemia. N Engl J Med 298:526–530Google Scholar
  13. 13.
    Stacpoole PW, Harman EM, Curry StH, Baumgartner TG, Misbin RI (1983) Treatment of lactic acidosis with dichloroacetate. N Engl J Med 309:390–396Google Scholar
  14. 14.
    Stacpoole PW, Lorenz AC, Thomas RG, Harman EM (1988) Dichloroacetate in the treatment of lactic acidosis. Ann Intern Med 108:58–63Google Scholar
  15. 15.
    Stacpoole PW, Harwood HJ, Cameron DF, Curry SH, Samuelson DA, Cornwell DE, Sauberlich HE (1990) Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. Fundam Appl Pharmacol 14:327–337Google Scholar
  16. 16.
    Wargovich TJ, Macdonald RG, Hill JA, Feldman RL, Stacpoole PW, Pepine CJ (1988) Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol 61:65–70Google Scholar
  17. 17.
    Wassermann K, Whipp BJ, Koyal SN, Beaver WI (1973) Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol 35:236–243Google Scholar
  18. 18.
    Wassermann K, Hansen JE, Sue DY, Whipp BJ (1987) Protocols for exercise testing. In: Wassermann K, Hansen JE, Sue DY, Whipp BJ (eds) Principles for exercise testing and interpretation. Lea and Febiger, Philadelphia, pp 58–73Google Scholar
  19. 19.
    Whitehouse S, Cooper RH, Randle PJ (1974) Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J 14:761–774Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Bernhard Ludvik
    • 1
  • Gert Mayer
    • 1
  • Sibylle Stifter
    • 1
  • Dinah Putz
    • 1
  • Ursula Barnas
    • 1
  • Helmut Graf
    • 1
  1. 1.Klinik für Innere Medizin III, Department of NephrologyUniversity of ViennaViennaAustria
  2. 2.III. Medizinische Abt.KA RudolfstiftungViennaAustria

Personalised recommendations